TNYA

TENAYA THERAPEUTICS INC

TNYA·87990A106·US·Common Stock·Healthcare - Biotechnology-Activist

TNYA (TENAYA THERAPEUTICS INC) is held by 57 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($5.9M), MILLENNIUM MANAGEMENT LLC ($3.8M), CITADEL ADVISORS LLC ($2.9M). Net institutional sentiment: Mixed.

57
Holders
(4 Elite)
$26.7M
Total Value
64% (55)
Consensus
35 buying - 20 selling
13F: Insider & Congress:
TNYASmart Money Verdict
View all
Held by 57 funds
4 elite
Who's Trading
InsiderAFAli FarazSell $3KMay 18, 2026
ActivistCIThe Column Group III, LP0.0%Feb 26, 2026
InsiderCLCOLUMN GROUP III GP, LPSell $928KFeb 25, 2026
InsiderCLCOLUMN GROUP III GP, LPSell $1.0MFeb 25, 2026
InsiderCLCOLUMN GROUP III GP, LPSell $215KFeb 24, 2026
InsiderCLCOLUMN GROUP III GP, LPSell $190KFeb 24, 2026
InsiderCLCOLUMN GROUP III GP, LPSell $97KFeb 23, 2026
InsiderCLCOLUMN GROUP III GP, LPSell $86KFeb 23, 2026
InsiderCLCOLUMN GROUP III GP, LPSell $171KFeb 20, 2026
ActivistWoodline Partners LPWoodline Partners LP5.0%Aug 14, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
8.5M$5.9M0.0%+58.18%
38
Increased
5.5M(+18.2%)$3.8M0.0%-33.20%
31
Unchanged
4.2M$2.9M0.0%+24.29%
0
Increased
3.7M(+100.7%)$2.6M0.0%+46.12%
42
Decreased
3.7M(-6.2%)$2.6M0.0%-23.82%
0
Increased
2.7M(+92.4%)$1.9M0.0%+38.67%
41
Increased
1.6M(+30.7%)$1.1M0.0%-82.87%
32
Increased
1.3M(+1.1%)$886,5420.0%-20.53%
25
Increased
1.2M(+73.9%)$817,0890.0%+33.01%
37
New
1M$702,8660.0%+58.18%
34
Unchanged
915,705$631,8360.0%-56.72%
0
Increased
708,721(+59.0%)$490,7180.0%-48.01%
23
Increased
665,180(+14.8%)$460,3050.0%-7.35%
27
New
348,268$241,1410.0%+58.18%
32
Increased
310,654(+28.6%)$215,0970.0%-79.81%
20
Increased
308,772(+8.5%)$213,7940.0%-16.31%
17
Increased
268,505(+28.8%)$185,9120.0%-31.18%
19
Increased
235,500(+27.3%)$163,0600.0%-15.18%
28
Decreased
207,100(-12.4%)$143,3960.0%+24.29%
0
Increased
154,801(+127.7%)$107,1840.0%+1.84%
24

Showing 1-20 of 65

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used